GLP-1 linked to lower alcohol consumption

New UK research suggests GLP-1 weight-loss drugs are having an impact on drinking habits, with users cutting how often they drink by nearly a third. The findings add fresh momentum to the growing trend towards moderation.

A study by KAM, in partnership with Drinkaware, found drinking frequency among GLP-1 users fell 29%, from 3.1 to 2.2 days per week. Alcohol intake also declined, dropping 16% to 3.6 units weekly. Spending followed suit, with home consumption down 22% and on-trade spend per visit falling 30%.

Researchers say the shift is driven by reduced cravings, with over a third of users reporting less desire to drink. Some also experience discomfort when consuming alcohol.

With up to 5.5 million UK adults estimated to be using GLP-1 drugs, the impact could be significant. While socialising remains important, experts say consumers are increasingly opting for moderation, creating both a challenge and an opportunity for the drinks industry.